-
Teva launches generic ADHD drug
NORTH WALES, Pa. – Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday.
The drug maker announced the launch of dexmethylphenidate hydrochloride extended-release capsules, a generic version of Novartis' Focalin XR.
Focalin XR has annual sales of about $202 million, according to IMS Health.
-
Enlisting patients in the drive to improve Rx
Nowhere is the need to engage more effectively with patients more apparent than in the area of medication adherence.
“Over 50% of patients with chronic conditions stop taking their medications,” said Diane Gilworth, a geriatric nurse practitioner and chief clinical officer for Dovetail Health. “So we have to find a way to help patients take better care of themselves.”